Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Katrin Töpfer

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Molecular Cancer|June 3, 2014
Survivin safeguards chromosome numbers and protects from aneuploidy independently from p53Ralf Wiedemuth, Barbara Klink, Katrin Töpfer, et al.
Journal of Biomedicine & Biotechnology|December 23, 2011
Tumor evasion from T cell surveillanceKatrin Töpfer, Stefanie Kempe, Nadja Müller, et al.
The Prostate|July 24, 2014
Redirection of CD4+ and CD8+ T lymphocytes via a novel antibody-based modular targeting system triggers efficient killing of PSCA+ prostate tumor cellsClaudia Arndt, Anja Feldmann, Katrin Töpfer, et al.
Neuro-Oncology|July 27, 2011
RNA interference targeting survivin exerts antitumoral effects in vitro and in established glioma xenografts in vivoSandy Hendruschk, Ralf Wiedemuth, Achim Aigner, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|May 12, 2015
Engineering NK Cells Modified With an EGFRvIII-specific Chimeric Antigen Receptor to Overexpress CXCR4 Improves Immunotherapy of CXCL12/SDF-1α-secreting GlioblastomaNadja Müller, Susanne Michen, Stefanie Tietze, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 6, 2015
DAP12-based activating chimeric antigen receptor for NK cell tumor immunotherapyKatrin Töpfer, Marc Cartellieri, Susanne Michen, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 22, 2011
Self-complementary AAVs induce more potent transgene product-specific immune responses compared to a single-stranded genomeTeLang Wu, Katrin Töpfer, Shih-Wen Lin, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 10, 2012
Novel humanized and highly efficient bispecific antibodies mediate killing of prostate stem cell antigen-expressing tumor cells by CD8+ and CD4+ T cellsAnja Feldmann, Claudia Arndt, Katrin Töpfer, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 21, 2011
Retargeting of human regulatory T cells by single-chain bispecific antibodiesStefanie Koristka, Marc Cartellieri, Anke Theil, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 23, 2010
Augmentation of primary influenza A virus-specific CD8+ T cell responses in aged mice through blockade of an immunoinhibitory pathwayLauren DiMenna, Brian Latimer, Elizabeth Parzych, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Molecular Cancer|June 3, 2014
Survivin safeguards chromosome numbers and protects from aneuploidy independently from p53Ralf Wiedemuth, Barbara Klink, Katrin Töpfer, et al.
Journal of Biomedicine & Biotechnology|December 23, 2011
Tumor evasion from T cell surveillanceKatrin Töpfer, Stefanie Kempe, Nadja Müller, et al.
The Prostate|July 24, 2014
Redirection of CD4+ and CD8+ T lymphocytes via a novel antibody-based modular targeting system triggers efficient killing of PSCA+ prostate tumor cellsClaudia Arndt, Anja Feldmann, Katrin Töpfer, et al.
Neuro-Oncology|July 27, 2011
RNA interference targeting survivin exerts antitumoral effects in vitro and in established glioma xenografts in vivoSandy Hendruschk, Ralf Wiedemuth, Achim Aigner, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|May 12, 2015
Engineering NK Cells Modified With an EGFRvIII-specific Chimeric Antigen Receptor to Overexpress CXCR4 Improves Immunotherapy of CXCL12/SDF-1α-secreting GlioblastomaNadja Müller, Susanne Michen, Stefanie Tietze, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 6, 2015
DAP12-based activating chimeric antigen receptor for NK cell tumor immunotherapyKatrin Töpfer, Marc Cartellieri, Susanne Michen, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 22, 2011
Self-complementary AAVs induce more potent transgene product-specific immune responses compared to a single-stranded genomeTeLang Wu, Katrin Töpfer, Shih-Wen Lin, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 10, 2012
Novel humanized and highly efficient bispecific antibodies mediate killing of prostate stem cell antigen-expressing tumor cells by CD8+ and CD4+ T cellsAnja Feldmann, Claudia Arndt, Katrin Töpfer, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 21, 2011
Retargeting of human regulatory T cells by single-chain bispecific antibodiesStefanie Koristka, Marc Cartellieri, Anke Theil, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 23, 2010
Augmentation of primary influenza A virus-specific CD8+ T cell responses in aged mice through blockade of an immunoinhibitory pathwayLauren DiMenna, Brian Latimer, Elizabeth Parzych, et al.
Pageof 2